Fingerprint
Dive into the research topics of 'Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma
Yvette L. Kasamon, Heather A. Jacene, Christopher D. Gocke, Lode J. Swinnen, Douglas E. Gladstone, Brandy Perkins, Brian K. Link, Leslie L. Popplewell, Thomas M. Habermann, Joseph M. Herman, William H. Matsui, Richard J. Jones, Richard F. Ambinder
Research output: Contribution to journal › Article › peer-review
56
Scopus
citations